electroCore to Announce Second Quarter June 30, 2026, Financial Results on Thursday, August 6, 2026

electroCore (Nasdaq: ECOR) will report financial results for the second quarter ended June 30, 2026, after the market close on Thursday, August 6, 2026.

Rhea-AI Summary

electroCore (Nasdaq: ECOR) will report financial results for the second quarter ended June 30, 2026, after the market close on Thursday, August 6, 2026. Management will host a results webinar at 4:30 PM EDT, with investor access via phone dial-in, webinar ID, passcode, and an online registration link.

Argus Jul 30 session 3 alerts

+3.62% close to close 0.1x rel. volume Open Argus

Details

Market move: ECOR +3.62% in the Jul 30 session. 2Q26 earnings report

+2.1% Peak Tracked

$54.06M Mkt Cap at Peak Alert

On Jul 30, the day this news came out, ECOR closed 3.62% above the previous close. Argus tracked a peak move of +2.1% during that session. Our momentum scanner recorded 3 alerts for this stock that day.

Data tracked by StockTitan Argus for the Jul 30 session.

Key Figures

Quarter End: June 30, 2026 Results Date: August 6, 2026 Webinar Time: 4:30 PM EDT

Quarter End

June 30, 2026

Second quarter financial results

Results Date

August 6, 2026

After market close

Webinar Time

4:30 PM EDT

Management review of financial results

Previous Earnings date Reports

2 past events · Latest: Apr 29

Same Type 2 events

1. Apr 29

   Earnings date

   24h Move

   +0.0%

   Announced first-quarter results date and management webinar details

2. Mar 09

   Earnings date

   24h Move

   -3.1%

   Announced fourth-quarter and full-year results date and webinar

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

bioelectronic medicine

1 terms

bioelectronic medicine medical

"a commercial-stage bioelectronic medicine and wellness company"

Bioelectronic medicine uses small implanted or wearable devices to change the body’s electrical or nerve signals to prevent or treat illness instead of relying only on drugs. Think of it like a pacemaker for different organs: it can turn problematic signals up or down to relieve symptoms. For investors it matters because successful devices can open new treatment markets, offer recurring revenue from device sales and follow‑up care, and carry clear clinical and regulatory risks that affect value.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

ROCKAWAY, N.J., July 30, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that it will report financial results for the second quarter ended June 30, 2026, after the close of the market on Thursday, August 6, 2026.

Management will host a webinar at 4:30 PM EDT to review the financial results and answer questions. Investors can access the webinar using the details below:

Thursday, August 6, 4:30 PM EDT
Dial-In: (646) 931-3860
Webinar ID: 849 0856 5421
Passcode: 305949
Registration Link: Click here to participate and ask questions on the call.

About electroCore, Inc.
electroCore, Inc. is a bioelectronic technology company whose mission is to improve health and quality of life through innovative non-invasive bioelectronic technologies. The Company’s two leading prescription products, gammaCore® non-invasive vagus nerve stimulation (nVNS) and Quell® neurostimulator, treat chronic pain syndromes through non-invasive neuromodulation technology. Additionally, the company commercializes its handheld, and personal use Truvaga™ and TAC-STIM™ nVNS products utilizing bioelectronic technologies to promote general wellness and human performance.

For more information, visit www.electrocore.com.

Contact:
ECOR Investor Relations
(973) 302-9253
investors@electrocore.com

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will electroCore (ECOR) report its Q2 2026 financial results?

electroCore will report Q2 2026 financial results on Thursday, August 6, 2026, after the market close. According to electroCore, the announcement covers the quarter ended June 30, 2026, and will be followed by a management webinar to discuss the results.

What time is electroCore’s Q2 2026 earnings webinar on August 6, 2026?

electroCore’s Q2 2026 earnings webinar starts at 4:30 PM EDT on August 6, 2026. According to electroCore, management will review the financial results and answer investor questions during this scheduled online session following the market close.

How can investors access the electroCore (ECOR) Q2 2026 earnings call?

Investors can access the electroCore Q2 2026 earnings call via webinar and phone dial-in at (646) 931-3860. According to electroCore, participants use Webinar ID 849 0856 5421 and Passcode 305949, with an online registration link available for asking questions.

What is the dial-in number and passcode for electroCore’s Q2 2026 earnings webinar?

The dial-in number is (646) 931-3860 and the passcode is 305949. According to electroCore, investors should also use Webinar ID 849 0856 5421 and may register through the provided online link to participate and submit questions.

Will electroCore management take questions on the Q2 2026 earnings call?

Yes, management plans to answer questions during the Q2 2026 earnings webinar. According to electroCore, investors can use the registration link to participate and submit questions, following the company’s review of financial results at 4:30 PM EDT on August 6, 2026.